THANK YOU TO ALL THE FUHEL PARTICIPANTS & MENTORS!
The 2021 edition of the FUHEL Programme has been hold during the 8th International Workshop on Lung Health – VIRTUAL EDITION
Despite COVID-19 situation the enthusiasm of participants and mentors has been great!
3 Working days spent in a path throughout the clinical and observational research world, focused on respiratory medicine.
Some comments from the participants:
“Programme was outstanding and mentors were great. It will help to promide systemic reviews, analizing data in proper way, better understanding of meta-analysis and of course its relevant because as far as I am phd student and doing research. I do epecially like the way mentors provide us guidance during this year. They organized us to analyse and they also provide us with guidance how to make analysys. So in that way we were able to learn lots of useful and profound information” Yuliya Fedorchenko, Ivano-Frankivsk National Medical University, Ukraine
“The FUHEL Programme has been essential for young researchers to understand fundamentals of research methodology, data collection and article writing.” Olga Nesterovska HSEI ‘Bukovinian state medical university’, Ukraine
“The knowledge acquired with the programme is extremely necessary for young scientists.” Kseniia Suska – State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”
“FUHEL provides young clinicians and PHD students with a great idea of scintific publishing” Fatima Alhamed Alduihi – Aleppo University, Syrian Arab Republic
During the last edition of the International Workshop on Lung Health, the Organizing Committee realized that the Future Leaders Mentoring Programme is one of the most important and attractive activity of the meeting.
The idea we came up with in Prague was to enlarge the Programme to develop a âNew Hubâ for Young Clinicians and Researchers in Respiratory Medicine.
The Programme has been re-designed accordingly starting from its title, FuHeL (Future Health Leader of the Lungs) Mentoring Programme. Read more about the new programme features below.
Are you a young clinicians or researcher/student and/or PhD Resident?
Do you want to spend the 3 Workshop days virtually mentored by Prof. Aliberti, Prof. Heffler and Prof. Sotgiu?
Read more about the Programme and don’t miss the opportunity to candidate yourself to be part of the IWHL 2021 – Future Leaders Mentoring Programme
The Programme â with the full respect of the COVID 19 prevention regulations â will take place as virtual edition from January 13th, to January 15th, 2021. The FuHeL Participants will benefit of a virtual working room, reserved to the Programme, where they can work with the mentors.
THE PROGRAMME FEATURES
MENTORS OF THE PROGRAMME
The Future Leaders’ Mentoring Programme is open to up 20 Residents / PhD students under 42 in Respiratory Medicine from different European Universities and Hospitals.
In order to apply for the Future Leaders mentoring programme the following documents are required
Motivational Letter where research, clinical interests and focus will be underlined
All these documents and details must be sent throughout the on line procedure
AIMS OF THE PROGRAMME
The 2021 Edition of the Future Leaders Mentoring Programme will see the birth of the “FuHeL (Future Health Leader of the Lungs) Mentoring Programme, a scientific âhubâ for the Young Researchers and clinicians of the worldwide respiratory medicine, which aim to spend 3 days working with the Mentors, which will give important indications about how to approach to clinical, observational and methanalysis scientific publications.”
The mentors of the programme – Prof. Stefano Aliberti, Prof. Heffler and Prof. Giovanni Sotgiu – require to each candidate to have a specific interest in clinical and scientific research. During the 3 Workshop Days the Programme will give to participants tools, tips and guidelines about how explore clinical, observational and methanalysis publications.
Francesco Blasi, MD, FERS is Professor of Respiratory Medicine in the Department of Pathophysiology and Transplantation at the University of Milan, Italy, as well as Head of Internal Medicine Department and Respiratory Unit of the Fondazione IRCCS Caâ Granda Ospedale Maggiore Policlinico, Milan, Italy. He is also director of the Adult Cystic Fibrosis Center of the Lombardia Regional Referral CF Center and currently a member of the Board of Directors of the University of Milan. From 2012â2013, he was president of European Respiratory Society (ERS) and from 2016â2017 president of the Italian Respiratory Society (SIP/IRS). From 2017â2018, he was president of the Italian Respiratory Society Research Center (SIP/IRS Centro Ricerche). Professor Blasi has published more than 350 papers in international journals (WEB of Science (01.12.2018) h-index : 50 Citations: 8620; SCOPUS (01.12.2018) : h-index:53 Citations:10680 ; Google Scholar (1.4.2019): h-index: 70, Citations: 17,668). His research interests include pneumonia, COPD, bronchiectasis, tuberculosis and NTM infections, cystic fibrosis and lung transplantation.
Professor G. Walter Canonica is director of the Personalized Medicine Center: Asthma and Allergies at Humanitas Research Hospital in Milan (Italy). He has been Director of the Allergy & Respiratory Diseases Clinic, Genoa University -Italy a Galen Centre of Excellence (1997-2016) Since 1995 he is full Professor of Allergy and Respiratory Diseases, Dept of Int Medicine, Genoa University
Professor Canonicaâs research interests include examination of the molecular events and interactions between immunocompetent cells, inflammatory cells and epithelial cells in allergic inflammation and airway remodelling. He has been President of the World Allergy Association (2007-2009) and of the Italian Association for Allergology, Asthma and Immunology (2014-2017). He personally published more than 230 scientific works on the most relevant and influent specialized journals.
Stefano Aliberti is Associate Professor in Respiratory Medicine at the University of Milan and Respiratory Consultant at the Policlinico University Hospital, Milan, Italy. He received his medical degree from the University of Milan and completed his clinical research training at the University of Louisville, KY, USA, working as member of the Community-Acquired Pneumonia Organization Database.
Most of his research over the past fifteen years has been focused on both acute and chronic respiratory infections, and particularly on community-acquired pneumonia, bronchiectasis and non-tuberculous mycobacteria (NTM). He is former Head of the Respiratory Infections Assembly of the European Respiratory Society, chair of the European Registry of Bronchiectasis (EMBARC), the Italian Registry of Bronchiectasis (IRIDE) and the Italian Registry of pulmonary NTM (IRENE). He leads the Policlinico Bronchiectasis Program which includes a multidisciplinary team of physicians and respiratory physiotherapists taking care bronchiectasis, PCD and NTM patients at the Policlinico Hospital in Milan.
Prof. Stefano Centanni studied medicine at the School of Medicine of the University of Milan, where he received his Medical Doctor Degree in 1979. Following an internship at the pulmonary Division of the McMaster University, Hamilton, Canada, in 1981 and a fellowship at the Pulmonary Division of the Mount Sinai Medical Center at the University of Miami, Florida, USA, in 1982, he specialized in Allergology at the University of Medicine of Pavia, Italy, in 1985. He received a PhD in Pulmonary Diseases in 1998 at the University of Milan Medical School. From 1990 to 1996 he worked as Assistant Professor of the University of Milan at the Pulmonary Division of the Maggiore Hospital, Milan, and from 1996 to 2005 as Associate Professor at the Pulmonary Division of the San Paolo Hospital, University of Milan. Since 1996 he is Chief of the Pulmonary Division of the San Paolo Hospital, Milan, and in 2005 he became full professor of Respiratory Medicine at the University of Milan. Professor Centanni was Italian National Delegate 2007/2009 at the ERS and FERS Italian National Delegate from 2007 until 2012 and President of SIMeR (Italian Society of Respiratory Medicine â 2009/2011). Professor Centanni is author of more than one hundred scientific publications in international journals and several book chapters and books in the field of Respiratory Medicine.
J .Christian Virchow, MD, FRCP, FCCP, FAAAAI, is a Professor of Medicine and Pneumology and Head of the Departments of Pulmonary Medicine and Intensive Care Medicine in the University Medical Clinic at the University of Rostock, Germany. He is also the Medical Director of the Pulmonary Diagnostic Services and the Sleep Laboratory of the University of Rostock. He is Editor-in-Chief of RESPIRATORY MEDICINE and Visiting Professor of the China-Japan-friendship hospital in Beijing, PR China. He is a member of several medical organizations, including the American Thoracic Society, the European Respiratory Society, and the American College of Chest Physicians. Dr. Virchow serves as Associate Editor for several German journals in pulmonology and allergology and has served as an ad hoc reviewer for Chest, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology, the European Respiratory Journal and many others. He is the author or coauthor of more than 200Â peer reviewed articles for journals such as JAMA, the American Journal of Respiratory and Critical Care Medicine, Chest, and European Respiratory Journal and author of several chapters for text books. He received his doctoral degree from the University of TĂźbingen, Germany after attending Medical School in Marburg and Giessen, Germany and ZĂźrich, Switzerland. Dr. Virchow completed his residency in internal medicine at University Medical Clinic in Freiburg, Germany, and his fellowship in pulmonary medicine at the Department of Pneumology at the University of Freiburg, Germany under Prof. H. Matthys. His special interests are research into the mechanisms of inflammation in chronic obstructive lung diseases such as asthma and COPD as well as the treatment of these conditions.
Professor Tobias Welte is the Head of the Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover. 1978 -1985: Study of human medicine, Hannover Medical School 1985 â 88/90: Department of Internal Medicine, County Hospital Lehrte 1989: Residentialship, Massuchusetts General Hospital Boston, USA 1990-1994: Fellow, Department of Respiratory Medicine, Hannover Medical School 1992: Specialist for Internal Medicine 1994: Specialist for Respiratory Medicine 1994: MD 1995: Specialist Intensive Care Medicine 2000: Habilitation for âInternal Medicineâ 2002: Specialist for Infectious Disease Academic Appointments: 1994 â 2004 : Head of the Division of Respiratory Medicine and Intensive Care, University of Magdeburg 2003: Appointment C3 Professorship for Respiratory Medicine University of Magdeburg, not accepted since 2004: W3-Professorship, Head of the Department of Respiratory Medicine, Hannover Medical School 2015: Appointment Professorship for Pneumology, University of Vienna, not accepted Other (selected) Professional Activities: 1994 â today: Project leader in more than thirty research projects funded by DFG, BMBF and EU Since 2001: Co-ordinating board of BMBF-competence networks PROGRESS, ASCONET and CAPNETZ as well as Chairman of CAPNETZ Foundation 2007-2011: Speaker of the BMBF funded Clinical Study Center Hannover (KS-MHH) since 2011: Member of the board of directors of the German Center for Lung Research (DZL) and director of the Hannover DZL site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease Hannover) since 2011: Member of the Internal Advisory Board of the German Center of Infectious Disease Research (DZIF) 2008-2010: President of the German Society of Medical Intensive Care Medicine 2009-2015: Chief Editor of the European Respiratory Monograph since 2008: Member, since 2012 Spokesman of DFG-Fachkollegium âInflammationâ 2009-2013: President of the German Sepsis Society 2012-2014 President of German Society of Pneumology 2018-2019: President of the European Respiratory Society (ERS)
Additional Information: 2014 Appointment as Fellow of the European Respiratory Society (FERS)
Consultant and Head of the department Pulmonary and Critical Care Medicine, Galaxy institute of Pulmonology, Galaxy Hospital, 5 AGCR enclave, Delhi 110092 and Yashoda Superspeciality Hospital , Kaushambi, UP. “My primary research focuses are Interstitial Lung diseases, Advanced COPD/Respiratory failure, Pulmonary Infections, Sleep Medicine.”
RISING STAR SESSION SCIENTIFIC WORK:
âDifferences in Tobacco smoke associated and Biomass fuel associated Chronic Obstructive Pulmonary disease (COPD) â A unique disease of the Indian Subcontinentâ Biomass fuel associated COPD is a unique subset of COPD, encountered in rural India. Most of the patients are unsuspecting non smoker, females. The diagnosis of COPD is commonly missed in these patients, they present late in the course of disease and have poor health seeking behavior.
Â Infections and Cystic Fibrosis Unit, Division of Immunology, Transplantation and Infectious Diseases; Ospedale San Raffaele. UniversitĂ Vita-Salute San Raffaele MILANO (Italy) “My primary research focuses on studying immunity, with particular attention on host-pathogen interaction in the context of airway diseases. Using different model of in vivo and in vitro infections, I have demonstrated the role of IL-17/IL-17R immune axis in modulating host defense and immunopathology in the lung. Based on my skills in immunology, microbiology and genetics, my current research interests are focused on the mechanistic comprehension of the immune response during chronic respiratory disease.”
RISING STAR SESSION SCIENTIFIC WORK:
âThe IL-17s/IL-17Rs axis in airway defense and immunopathology during chronic respiratory disease associated to Pseudomonas aeruginosa infections.â The exaggerated inflammation and tissue damage, associated to persistent infections, are central pathological features of chronic respiratory diseases. We are interested in elucidating whether the IL-17 cytokines family may modulate chronic lung disease progression associated with Pseudomonas aeruginosa persistent infections.